Shanghai HeartCare Medical Technology Corporation Limited

SEHK:6609 Stock Report

Market Cap: HK$762.1m

Shanghai HeartCare Medical Technology Future Growth

Future criteria checks 3/6

Shanghai HeartCare Medical Technology is forecast to grow earnings and revenue by 111.8% and 1.8% per annum respectively while EPS is expected to grow by 188.3% per annum.

Key information

111.8%

Earnings growth rate

188.3%

EPS growth rate

Medical Equipment earnings growth39.9%
Revenue growth rate1.8%
Future return on equityn/a
Analyst coverage

Low

Last updated03 Sep 2024

Recent future growth updates

Recent updates

Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely

Sep 27
Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely

Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio

Aug 01
Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio

We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Jan 23
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Aug 30
Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Aug 09
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

May 07
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Nov 29
We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Earnings and Revenue Growth Forecasts

SEHK:6609 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202538737N/A-622
12/31/20242951N/A-192
6/30/2024251-4528-9N/A
3/31/2024242-69-34-49N/A
12/31/2023232-94-96-88N/A
9/30/2023224-141-176-142N/A
6/30/2023216-188-255-195N/A
3/31/2023199-194-280-231N/A
12/31/2022183-200-304-267N/A
9/30/2022160-185-318-272N/A
6/30/2022137-169-332-278N/A
3/31/2022115-188-298-243N/A
12/31/202190-194-260-206N/A
9/30/202166-242-216-169N/A
6/30/202143-290-171-133N/A
3/31/202128-244-129-102N/A
12/31/202015-214-90-75N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6609 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: 6609 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 6609 is expected to become profitable in the next 3 years.

Revenue vs Market: 6609's revenue (1.8% per year) is forecast to grow slower than the Hong Kong market (7.8% per year).

High Growth Revenue: 6609's revenue (1.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 6609's Return on Equity is forecast to be high in 3 years time


Discover growth companies